Eli Lilly has been quietly reshaping how it presents itself, not just the drugs it sells. Internally, they’ve built a dedicated brand team that treats the company like a consumer product, crafting a consistent voice across everything from conference booths to social posts. The goal isn’t flashier ads; it’s to make the company feel trustworthy and relatable to patients, doctors, and even investors.
The culture leans heavily on data. Teams track how messages perform in real time, tweaking language and visuals based on what actually resonates. That means a lot of A/B testing, digital dashboards, and cross‑functional meetings where marketers, scientists, and compliance folks all weigh in. It’s a collaborative loop rather than a top‑down “big‑idea” rollout.
Another shift is the focus on storytelling that centers patients’ experiences. Rather than highlighting the molecule, they spotlight real‑world outcomes, using patient videos and case studies to humanize the brand. This approach is meant to build long‑term loyalty, not just a one‑off prescription.
Overall, Lilly’s marketing isn’t about grand hype; it’s about steady, data‑driven communication that aligns the company’s identity with the everyday lives of the people it serves.
LONDON — Sanofi on Monday named a new leader for its research and development efforts, as the French pharma company looks to reinvigorate its pipeline under new CEO Belén Garijo. Paulo Fontoura will become global head of R&D for Sanofi’s pharma work starting Sept. 1. A neurologist by training, Fontoura was most recently the chief medical officer at Xaira Therapeutics, an AI-focused drug discovery company. He previously spent more than 15 years at Roche. Fontoura is replacing Houman Ashrafian, who joined Sanofi in 2023 following years as a health care investor. Sanofi said Ashrafian “has decided to pursue an opportunity outside the company.”
Emanuel’s advice isn’t built on a single trial; it’s a synthesis of decades of cohort studies, meta‑analyses, and his own oncology practice. He starts by saying that chasing “longevity” as a number is a distraction—what matters is staying functional and pain‑free.
The most potent lever, he notes, is not a new workout but the quality of what we eat. Large observational studies link ultra‑processed foods and sugary drinks to higher rates of heart disease, diabetes, and cancer, while diets rich in whole foods, modest alcohol, and occasional treats (yes, ice cream) correlate with better health outcomes.
Social connection is another hard‑won finding: neuroimaging work shows that regular, supportive friendships reshape stress pathways and improve immune function. He recommends nurturing a few close relationships rather than scattering attention across many shallow contacts.
From there he distills six practical habits: prioritize sleep, move regularly but without over‑training, eat mostly plant‑based foods, enjoy treats in moderation, stay socially engaged, and keep learning. Each rule mirrors the strongest evidence we have—mostly large‑scale, long‑term studies—so they’re less hype and more a realistic roadmap for feeling better as we age.
I’m back on the road, driving a van through Montana with my friend Lauren. We’ve landed at Zootown, the music festival we loved in Missoula last year, and we’ve already spent eight hours on our feet just to snag a spot by the railing for The Chicks. It’s exhausting, but the energy is wild‑happy, and the music makes every sore leg worth it.
We’re camping by a lake now, and after a few days of rest I’ll head north toward Glacier. If you have any trail or campsite tips, I’d love to hear them—just drop a note. While I’m out here, I’ve been cooking a super simple 10‑minute dinner that I’ll share soon, and I’ve also found a new lip gloss and a boutique beauty shop that I’m obsessed with.
Lastly, remember the survey I sent out last year about a project I’m building? I’ve been using the feedback to shape it, and I’m gearing up to open early access. If you want in, just leave your email and I’ll keep you posted.
Thanks for all the thoughtful replies you’ve sent my way; they really mean a lot. Talk soon!
Early‑stage detection of endometriosis and adenomyosis in teens or young adults can cut the amount of tissue that later forms by roughly forty percent, according to a review of imaging and surgical data. The author emphasizes that many lesions are missed because symptoms are often dismissed as normal menstrual pain, so a low threshold for pelvic ultrasound or MRI in persistent cases can shift the disease trajectory dramatically.
Fertility implications are tied to both the location and the depth of the lesions. Small implants on the ovaries or within the uterine wall can disrupt egg quality and implantation, while extensive scarring can block the fallopian tubes. The paper cites cohort studies showing that women diagnosed before age 30 tend to have higher pregnancy rates after treatment than those identified later, suggesting that timing matters as much as the surgical approach.
Reproductive aging adds another layer: chronic inflammation from untreated disease may accelerate ovarian reserve loss. Hormonal profiles from longitudinal observations indicate that women with long‑standing endometriosis often reach menopause a few years earlier than peers, though the exact magnitude varies across populations. This underscores the importance of monitoring anti‑Müllerian hormone levels in patients with known disease.
Emerging therapies range from refined hormonal regimens that target specific receptors to minimally invasive ablative techniques guided by real‑time imaging. Early trials of a selective progesterone receptor modulator show modest symptom relief with fewer side effects than traditional GnRH agonists, but the data are still limited to small randomized cohorts. Likewise, robotic‑assisted excision of deep infiltrating lesions is being evaluated for safety and fertility outcomes, and the initial results are encouraging, though larger studies are needed before it becomes standard practice.
I’m excited to share this clafoutis‑magique—a hybrid of a classic French clafoutis and a gateau magique. The batter splits into three layers as it bakes: a dense, chewy base, a creamy custard middle, and a pillowy, soufflé‑like top. It’s a textural surprise that feels both comforting and elegant.
The trick is infusing whole milk with bay leaf and cinnamon, then cooling it before mixing with eggs, sugar, butter, flour, almond flour, and a pinch of salt. You fold in three batches of stiff‑peaked egg whites, leaving a few lumps so the layers can form. Spread pitted cherries on the bottom, pour the batter over them, and bake at 160 °C (150 °C with a fan) for 45–55 minutes.
After it cools, chill the dish for a few hours, then serve at room temperature, dusted with icing sugar. The result is a brunch‑ready cake that’s as pretty as it is delicious—dense cherry‑laden clafoutis meets the airy magic of a gateau magique.
I’m excited to share a quick take on a chocolate sorbet that leans on water instead of cream, so the chocolate comes through bright and clean. It’s not the buttery richness you’d expect from ice cream, but the lightness lets the cocoa shine, almost like a chilled ganache.
What’s fun about this base is how easily it takes on extra flavors. You can stir in citrus zest, a pinch of spice, coffee, herbs, or even floral waters. The author has tried a lot, but the standout for summer fruit vibes is a second‑flush Darjeeling tea. That tea brings a honeyed sweetness and a subtle hint of ripe Muscat grapes that meshes nicely with the cocoa.
The result is a refreshing scoop that feels both familiar and a little unexpected—chocolatey without being heavy, with a gentle tea‑infused fruit note that makes it feel special enough for a warm day or a quiet evening at home.
Send this story to anyone — or drop the embed into a blog post, Substack, Notion page. Every play sends rev-share back to storyflo · health and longevity.
We’ve simplified responses to 👍 / 👎. Past comments are archived but no longer visible.
